Introduction: Old age is an independent risk factor (RF) for severe COVID-19; evidence for clinico-epidemiological characteristics among elderly COVID-19 patients is scarce. We aimed to analyze clinical and epidemiological characteristics and comorbidities associated with COVID-19 inpatients in age-stratified populations of an elderly COVID-19 cohort. Methods: We conducted a retrospective cohort study, using nationwide registry data of COVID-19 patients hospitalized before October 31, 2020 (major information entered in the registry as of December 28, 2020). Participants were divided by age according to the Japan Geriatrics Society and the Japan Gerontological Society: pre-old (65–74 years), old (75–89 years), and super-old (≥90 years). Multivariable logistic regression (MLR) analyses were conducted to identify stratified risk and relationships with comorbidities associated with worse outcomes in different age-groups of elderly patients. Demographics and supportive care were evaluated by category. Results: Data of 4,701 patients from 444 hospitals were included. Most patients (79.3%) had at least one comorbidity; the proportion of patients with hypertension was high in all categories. The proportion of patients with dementia, cardiovascular disease, and cerebrovascular disease increased with age. The percentage of patients who underwent invasive mechanical ventilation/extracorporeal membrane oxygenation was lower in the super-old group. In total, 11.5% of patients died (5.3%, pre-old; 15.2%, old; and 22.4%, super-old). MLR showed that the risk of critical illness differed among age-groups. Male sex was a significant RF in all ages. Collagen disease, moderate to severe renal disorder, and dialysis were significant RFs in older patients, while hematological malignancies and metastatic tumors were more important RFs for severe disease in relatively younger patients. Most of the RFs for critical illnesses were associated with death. Conclusion: Differences in the epidemiological and clinical characteristics among the different age-groups were found.

1.
World Health Organization
.
Weekly epidemiological update [Internet]
.
2021 Mar 2
. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update.
2.
Saito
S
,
Asai
Y
,
Matsunaga
N
,
Hayakawa
K
,
Terada
M
,
Ohtsu
H
,
First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics
.
J Infect
.
2021 Apr
;
82
(
4
):
84
123
.
3.
National Institute of Infectious Diseases
.
Current situation of infection [Internet]
.
2021 Feb 11
. Available from: https://www.niid.go.jp/niid/en/2019-ncov-e/10196-covid19-ab23th-en.html.
4.
Ministry of Health
,
Labour
and
Welfare.
Situation report [Internet]
.
2021
.
Available from:
https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou_00006.html.
5.
O’Driscoll
M
,
Ribeiro Dos Santos
G
,
Wang
L
,
Cummings
DAT
,
Azman
AS
,
Paireau
J
,
Age-specific mortality and immunity patterns of SARS-CoV-2
.
Nature
.
2021 Feb
;
590
(
7844
):
140
5
.
6.
Pastor-Barriuso
R
,
Pérez-Gómez
B
,
Hernán
MA
,
Pérez-Olmeda
M
,
Yotti
R
,
Oteo-Iglesias
J
,
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study
.
BMJ
.
2020 Nov
;
371
:
m4509
.
7.
Perez-Saez
J
,
Lauer
SA
,
Kaiser
L
,
Regard
S
,
Delaporte
E
,
Guessous
I
,
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
.
Lancet Infect Dis
.
2021 Apr
;
21
(
4
):
e69
70
.
8.
Jordan
RE
,
Adab
P
,
Cheng
KK
.
COVID-19: risk factors for severe disease and death
.
BMJ
.
2020 Mar
;
368
:
m1198
. .
9.
Ministry of Health
,
Labour
and
Welfare.
Life expectancies at birth in some countries [Internet]
.
2019
.
Available from:
https://www.mhlw.go.jp/english/database/db-hw/lifetb19/dl/lifetb19-03.pdf.
10.
Matsunaga
N
,
Hayakawa
K
,
Terada
M
,
Ohtsu
H
,
Asai
Y
,
Tsuzuki
S
,
Clinical epidemiology of hospitalized patients with COVID-19 in Japan: report of the COVID-19 Registry Japan
.
Clin Infect Dis
.
2020 Sep
. Epub ahead of print.
11.
Harris
PA
,
Taylor
R
,
Thielke
R
,
Payne
J
,
Gonzalez
N
,
Conde
JG
.
Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support
.
J Biomed Inform
.
2009 Apr
;
42
(
2
):
377
81
. .
12.
Ouchi
Y
,
Rakugi
H
,
Arai
H
,
Akishita
M
,
Ito
H
,
Toba
K
,
Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society
.
Geriatr Gerontol Int
.
2017 Jul
;
17
(
7
):
1045
7
.
13.
National early warning score (NEWS). Standardising the assessment of acute-illness severity in the NHS
.
2021
. Available from: file:///Users/nomoto/Downloads/National%20Early%20Warning%20Score%20(NEWS)%20-%20Standardising%20the%20assessment%20of%20acute-illness%20severity%20in%20the%20NHS_0.pdf.
14.
R Core Team
.
R: a language and environment for statistical computing [Internet]
.
Vienna, Austria
:
R Foundation for Statistical Computing
;
2020
. Available from: https://www.R-project.org/.
15.
World Health Organization
.
Men, ageing and health: achieving health across the life span [Internet]
.
2001
. Available from: https://www.who.int/ageing/publications/men/en/.
16.
Liu
K
,
Chen
Y
,
Lin
R
,
Han
K
.
Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients
.
J Infect
.
2020 Jun
;
80
(
6
):
e14
8
. .
17.
Wang
L
,
He
W
,
Yu
X
,
Hu
D
,
Bao
M
,
Liu
H
,
Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up
.
J Infect
.
2020 Jun
;
80
(
6
):
639
45
.
18.
Ho
FK
,
Petermann-Rocha
F
,
Gray
SR
,
Jani
BD
,
Katikireddi
SV
,
Niedzwiedz
CL
,
Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants
.
PLoS One
.
2020 Nov
;
15
(
11
):
e0241824
.
19.
Statistics Bureau of Japan
.
Current population estimates as of October 1, 2019 [Internet]
.
2019
. Available from: https://www.stat.go.jp/english/data/jinsui/2019np/index.html#a15k01-a.
20.
Rhee
C
,
Baker
M
,
Vaidya
V
,
Tucker
R
,
Resnick
A
,
Morris
CA
,
Incidence of nosocomial COVID-19 in patients hospitalized at a large US academic medical center
.
JAMA Netw Open
.
2020 Sep 1
;
3
(
9
):
e2020498
.
21.
Yu
J
,
Ouyang
W
,
Chua
MLK
,
Xie
C
.
SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China
.
JAMA Oncol
.
2020 Jul
;
6
(
7
):
1108
10
. .
22.
Singhal
S
,
Kumar
P
,
Singh
S
,
Saha
S
,
Dey
AB
.
Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis
.
BMC Geriatr
.
2021 May
;
21
(
1
):
321
. .
23.
Pijls
BG
,
Jolani
S
,
Atherley
A
,
Derckx
RT
,
Dijkstra
JIR
,
Franssen
GHL
,
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
.
BMJ Open
.
2021
;
11
(
1
):
e044640
.
24.
CDC COVID-19 Response Team
.
Severe outcomes among patients with coronavirus disease 2019 (COVID-19) – United States, February 12–March 16, 2020
.
MMWR Morb Mortal Wkly Rep
.
2020 Mar
;
69
(
12
):
343
6
. .
25.
Wu
Z
,
McGoogan
JM
.
Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention
.
JAMA
.
2020 Apr
;
323
(
13
):
1239
42
. .
26.
Peckham
H
,
de Gruijter
NM
,
Raine
C
,
Radziszewska
A
,
Ciurtin
C
,
Wedderburn
LR
,
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
.
Nat Commun
.
2020 Dec
;
11
(
1
):
6317
.
27.
Griffith
DM
,
Sharma
G
,
Holliday
CS
,
Enyia
OK
,
Valliere
M
,
Semlow
AR
,
Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions
.
Prev Chronic Dis
.
2020 Jul
;
17
:
E63
.
28.
Passamonti
F
,
Cattaneo
C
,
Arcaini
L
,
Bruna
R
,
Cavo
M
,
Merli
F
,
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
.
Lancet Haematol
.
2020 Oct
;
7
(
10
):
e737
45
.
29.
Dai
M
,
Liu
D
,
Liu
M
,
Zhou
F
,
Li
G
,
Chen
Z
,
Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 Outbreak
.
Cancer Discov
.
2020 Jun
;
10
(
6
):
783
91
.
30.
Lee
LYW
,
Cazier
JB
,
Starkey
T
,
Briggs
SEW
,
Arnold
R
,
Bisht
V
,
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
.
Lancet Oncol
.
2020 Oct
;
21
(
10
):
1309
16
.
31.
Fitzgerald
GE
,
Maguire
S
,
Haroon
N
.
COVID-19: what do rheumatologists need to know?
Curr Rheumatol Rep
.
2021 Jan
;
23
(
1
):
5
. .
32.
D'Silva
KM
,
Serling-Boyd
N
,
Wallwork
R
,
Hsu
T
,
Fu
X
,
Gravallese
EM
,
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US “hot spot.”
Ann Rheum Dis
.
2020 Sep
;
79
(
9
):
1156
62
.
33.
Ye
C
,
Cai
S
,
Shen
G
,
Guan
H
,
Zhou
L
,
Hu
Y
,
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
.
Ann Rheum Dis
.
2020 Aug
;
79
(
8
):
1007
13
.
34.
Gianfrancesco
M
,
Hyrich
KL
,
Al-Adely
S
,
Carmona
L
,
Danila
MI
,
Gossec
L
,
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
.
Ann Rheum Dis
.
2020 Jul
;
79
(
7
):
859
66
.
35.
Hsu
CM
,
Weiner
DE
,
Aweh
G
,
Miskulin
DC
,
Manley
HJ
,
Stewart
C
,
COVID-19 infection among US dialysis patients: risk factors and outcomes from a national dialysis provider
.
Am J Kidney Dis
.
2021 Jan
;
77
(
5
):
748
56.e1
.
36.
Weiss
S
,
Bhat
P
,
Del Pilar Fernandez
M
,
Bhat
JG
,
Coritsidis
GN
.
COVID-19 infection in ESKD: findings from a prospective disease surveillance program at dialysis facilities in New York City and Long Island
.
J Am Soc Nephrol
.
2020 Nov
;
31
(
11
):
2517
21
. .
37.
Valeri
AM
,
Robbins-Juarez
SY
,
Stevens
JS
,
Ahn
W
,
Rao
MK
,
Radhakrishnan
J
,
Presentation and outcomes of patients with ESKD and COVID-19
.
J Am Soc Nephrol
.
2020 Jul
;
31
(
7
):
1409
15
.
38.
July
J
,
Pranata
R
.
Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis
.
Geriatr Gerontol Int
.
2021 Feb
;
21
(
2
):
172
7
. .
39.
Wang
Q
,
Davis
PB
,
Gurney
ME
,
Xu
R
.
COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US
.
Alzheimers Dement
.
2021
;
17
(
8
):
1297
306
.
40.
Miyashita
S
,
Yamada
T
,
Mikami
T
,
Miyashita
H
,
Chopra
N
,
Rizk
D
.
Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York
.
Geriatr Gerontol Int
.
2020 Jul
;
20
(
7
):
732
4
. .
41.
De Smet
R
,
Mellaerts
B
,
Vandewinckele
H
,
Lybeert
P
,
Frans
E
,
Ombelet
S
,
Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study
.
J Am Med Dir Assoc
.
2020 Jul
;
21
(
7
):
928
32.e1
.
42.
Lee
JY
,
Kim
HA
,
Huh
K
,
Hyun
M
,
Rhee
JY
,
Jang
S
,
Risk factors for mortality and respiratory support in elderly patients hospitalized with COVID-19 in Korea
.
J Korean Med Sci
.
2020 Jun
;
35
(
23
):
e223
.
43.
Cummings
MJ
,
Baldwin
MR
,
Abrams
D
,
Jacobson
SD
,
Meyer
BJ
,
Balough
EM
,
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
.
Lancet
.
2020 Jun
;
395
(
10239
):
1763
70
.
44.
Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society expert panel on the care of older adults with multimorbidity
.
J Am Geriatr Soc
.
2012 Oct
;
60
(
10
):
E1
25
. .
45.
Shoukat
A
,
Wells
CR
,
Langley
JM
,
Singer
BH
,
Galvani
AP
,
Moghadas
SM
.
Projecting demand for critical care beds during COVID-19 outbreaks in Canada
.
CMAJ
.
2020 May
;
192
(
19
):
E489
96
. .
46.
Li
R
,
Rivers
C
,
Tan
Q
,
Murray
MB
,
Toner
E
,
Lipsitch
M
.
Estimated demand for US hospital inpatient and intensive care unit beds for patients with COVID-19 based on comparisons with Wuhan and Guangzhou, China
.
JAMA Netw Open
.
2020 May
;
3
(
5
):
e208297
. .
47.
Mitsuya
H
.
Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs)
.
Glob Health Med
.
2020 Dec
;
2
(
6
):
343
5
. .
48.
Kokudo
N
,
Sugiyama
H
.
Hospital capacity during the COVID-19 pandemic
.
Glob Health Med
.
2021
;
3
(
2
):
56
9
. .
49.
Aw
D
,
Woodrow
L
,
Ogliari
G
,
Harwood
R
.
Association of frailty with mortality in older inpatients with COVID-19: a cohort study
.
Age Ageing
.
2020 Nov
;
49
(
6
):
915
22
.
50.
Blomaard
LC
,
van der Linden
CMJ
,
van der Bol
JM
,
Jansen
SWM
,
Polinder-Bos
HA
,
Willems
HC
,
Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study
.
Age Ageing
.
2021 May 5
;
50
(
3
):
631
40
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.